A detailed history of Gamma Investing LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Gamma Investing LLC holds 120 shares of OCUL stock, worth $1,089. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 38 215.79%
Holding current value
$1,089
Previous $331,000 209.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$8.33 - $11.47 $683 - $940
82 Added 215.79%
120 $1.03 Million
Q3 2024

Oct 04, 2024

BUY
$6.45 - $9.23 $245 - $350
38 New
38 $331,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $699M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.